Manufacturer for Citicoline Sodium - Gemcitabine Hydrochloride CAS 122111-03-9 API USP Standard High Purity – Ruifu

Short Description:


Product Detail

Related Products

Product Tags

Related Video

Feedback (2)

"Sincerity, Innovation, Rigorousness, and Efficiency" could be the persistent conception of our enterprise to the long-term to produce together with clients for mutual reciprocity and mutual profit for 210.54, Ezetimibe CAS 163222-33-1, Molecular Formula C11H9NO3, The main goal of our company is to live a satisfactory memory to all the customers, and establish a long term business relationship with buyers and users all over the world.
Manufacturer for Citicoline Sodium - Gemcitabine Hydrochloride CAS 122111-03-9 API USP Standard High Purity – Ruifu Detail:

Manufacturer with High Purity and Stable Quality
Chemical Name: Gemcitabine Hydrochloride 
CAS: 122111-03-9 
An Anticancer Agent
API USP Standard, High Quality, Commercial Production

Chemical Name Gemcitabine Hydrochloride
Synonyms Gemcitabine HCl; 2′-Deoxy-2′,2′-difluorocytidine; dFdC
CAS Number 122111-03-9
CAT Number RF-API41
Stock Status In Stock, Production Scale Up to Hundreds of Kilograms
Molecular Formula C9H12ClF2N3O4
Molecular Weight 299.66
Brand Ruifu Chemical
Item Specifications
Appearance White Crystal Powder, Odorless
Solubility Soluble in Water, slightly soluble in methanol, practically insoluble in acetone
Identifiaction IR IR spectrum should be concordant to that of the reference standard
Identifiaction Chloride Positive. It meets the requirements of the tests for chloride
Appearance of Solution Solution S in clear and not more intensely colored than reference solution BY7
pH 2.0~3.0
Specific Rotation +43.0° ~ +50.0°
Heavy Metals (Pb) ≤10ppm
Loss on Drying ≤1.0%
Residue on Ignition ≤0.10%
Related Substances   
Cytosine ≤0.10%
α-Isomer ≤0.10%
Any Other Impurity ≤0.10%
Total Impurities ≤0.20%
Methanol ≤0.30%
Toluene ≤0.01%
Dichloromethane ≤0.01%
Acetone ≤0.50%
Assay 98.0%~102.0% (Calculated on dried base) 
Test Standard United States Pharmacopeia (USP) Standard
Usage Active Pharmaceutical Ingredient (API)

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

1
2

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of Gemcitabine Hydrochloride (CAS: 122111-03-9) with high quality API. 

Gemcitabine Hydrochloride (CAS: 122111-03-9) is a clinically useful anticancer agent.1 It exerts its cytotoxic effects via the metabolites gemcitabine diphosphate (dFdCDP) and gemcitabine triphosphate (dFdCTP). dFdCTP is an inhibitor of DNA polymerase and is also incorporated in DNA strands resulting in termination of chain elongation and apoptosis. dFdCDP is an inhibitor of ribonucleotide reductase which results in depletion of deoxyribonucleotides needed for DNA synthesis. Gemcitabine metabolites have also been reported to inhibit cytidine triphosphate synthetase (CTP synthetase)2 and deoxycytidylate deaminase (dCMP deaminase)3. Topoisomerase 1 has also been shown to be a target for gemcitabine. 

Gemcitabine Hydrochloride (CAS: 122111-03-9) is a synthetic novel difluoro nucleoside drug that is anti-metabolic and antineoplastic. It is researched and developed by the Eli Lilly and Company and approved to be listed in South Africa, Sweden, the Netherlands, Australia and other countries in 1995. The United States Food and Drug Administration ( referred FDA) approved it as the first-line therapy for the clinical treatment of non-small cell lung cancer and pancreatic cancer. Gemcitabine hydrochloride, as a pro-drug, is a good substrate for the acidification of deoxygenation of thymine kinase phosphorus in the cell, and under the action of the enzyme, it can be converted into the following metabolites: gemcitabine mono-phosphate (dFdCMP), gemcitabine diphosphate (dFdCDP) and gemcitabine triphosphate (dFdCTP), among which the latter two are the active products. 


Product detail pictures:

Manufacturer for Citicoline Sodium - Gemcitabine Hydrochloride CAS 122111-03-9 API USP Standard High Purity – Ruifu detail pictures


Related Product Guide:

The corporation keeps to the operation concept "scientific management, superior quality and performance primacy, consumer supreme for Manufacturer for Citicoline Sodium - Gemcitabine Hydrochloride CAS 122111-03-9 API USP Standard High Purity – Ruifu , The product will supply to all over the world, such as: Lithuania, Sao Paulo, Yemen, Now, we are trying to enter new markets where we do not have a presence and developing the markets we have the already penetrated. On account of superior quality and competitive price , we will be the market leader, please don’t hesitate to contact us by phone or email, if you are interested in any of our products.
  • In China, we have many partners, this company is the most satisfying to us, reliable quality and good credit, it is worth appreciation.
    5 Stars By Honorio from Croatia - 2018.11.04 10:32
    As a veteran of this industry, we can say that the company can be a leader in the industry, select them is right.
    5 Stars By Liz from Sweden - 2017.09.30 16:36
    Write your message here and send it to us